Biology, Medicine, Intelligence.
Genyte is an independent initiative exploring where biology, medicine and artificial intelligence meet.
Scope
Genyte explores how artificial intelligence can help us understand living systems, from molecules and cells to patients and populations. The interest is in questions rather than products: how biological processes unfold, how disease develops and changes, and what machine learning can reveal that conventional analysis misses.
Areas of Interest
Machine learning for biological and clinical data
Disease progression and change over time
Precision medicine and early detection
Interpretable, research-led AI methods
Context
Biology and medicine generate more data than ever, yet understanding has not kept pace. Much of what is collected goes unexamined, and insight often arrives too late to matter. Genyte is interested in approaches that use artificial intelligence to understand the underlying biology, not only to automate existing tasks.
Status
Genyte began in 2026 with a focus on anticipating disease progression. It is now a space for open-ended exploration and is not under active development.